Bath & Body Works (NYSE:BBWI) Raised to “Hold” at BMO Capital Markets

Bath & Body Works (NYSE:BBWIGet Free Report) was upgraded by analysts at BMO Capital Markets to a “hold” rating in a report issued on Tuesday, Zacks reports.

Other analysts have also issued reports about the stock. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a report on Tuesday, August 18th. The Goldman Sachs Group lowered shares of Bath & Body Works from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $23.00 to $19.00 in a research note on Wednesday, July 8th. Weiss Ratings upgraded shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft set a $22.00 target price on shares of Bath & Body Works in a research report on Thursday, August 27th. Finally, Jefferies Financial Group boosted their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Four investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of “Hold” and an average price target of $22.13.

View Our Latest Research Report on BBWI

Bath & Body Works Trading Down 1.5%

BBWI stock opened at $17.45 on Tuesday. Bath & Body Works has a one year low of $14.27 and a one year high of $28.26. The firm has a 50-day moving average of $19.71 and a two-hundred day moving average of $19.63. The firm has a market capitalization of $3.52 billion, a PE ratio of 4.54, a P/E/G ratio of 1.82 and a beta of 1.38.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company’s revenue was down 2.3% on a year-over-year basis. During the same quarter last year, the business posted $0.30 EPS. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, equities research analysts anticipate that Bath & Body Works will post 2.73 earnings per share for the current year.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its stake in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after acquiring an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Bath & Body Works by 15.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after purchasing an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Bath & Body Works by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after purchasing an additional 36,684 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of Bath & Body Works during the 1st quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Read More

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.